Compensation in pancreatic β-cell function in subjects with glucokinase mutations

Jeppe Sturis, Irwin J. Kurland, Maria M. Byrne, Erik Mosekilde, Philippe Froguel, Simon J. Pilkis, Graeme I. Bell, Kenneth S. Polonsky

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

The relationship between the in vivo insulin secretory responsiveness of the pancreatic β-cell to glucose and the flux of glucose through the enzyme glucokinase was investigated in six subjects with heterozygous glucokinase mutations and in six matched control subjects. This was done by combining data published previously on the in vivo dose-response relationships between glucose and insulin secretion and on the in vitro enzymatic properties of wild-type and mutant forms of glucokinase. The flux of glucose through glucokinase (GK flux) in these subjects was estimated using a model based on the approximate Michaelis-Menten kinetics of wild-type and mutant forms of the enzyme. In two subjects with glucokinase mutations, which resulted in only a small reduction in enzymatic activity, the decrease in insulin secretion was directly proportional to the decrease in GK flux predicted using a Michaelis-Menten model for both mutant and wild-type glucokinase. However, in four subjects with glucokinase mutations, which resulted in severe reductions in enzymatic activity, insulin secretion was reduced compared with control subjects but less than predicted. This latter result implies the existence of a compensatory change in the β-cells of such subjects, which results in a relative increase in insulin secretory response. We propose modifications to the simple model relating glucose concentration and GK flux, including glucose-induced overexpression of the normal allele and a role of glucokinase regulatory protein. The modifications take into account the possibility that the degree of compensation may be directly related to the severity of the mutation.

Original languageEnglish (US)
Pages (from-to)718-723
Number of pages6
JournalDiabetes
Volume43
Issue number5
StatePublished - May 1994
Externally publishedYes

Fingerprint

Glucokinase
Mutation
Glucose
Insulin
Enzymes
Alleles

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Sturis, J., Kurland, I. J., Byrne, M. M., Mosekilde, E., Froguel, P., Pilkis, S. J., ... Polonsky, K. S. (1994). Compensation in pancreatic β-cell function in subjects with glucokinase mutations. Diabetes, 43(5), 718-723.

Compensation in pancreatic β-cell function in subjects with glucokinase mutations. / Sturis, Jeppe; Kurland, Irwin J.; Byrne, Maria M.; Mosekilde, Erik; Froguel, Philippe; Pilkis, Simon J.; Bell, Graeme I.; Polonsky, Kenneth S.

In: Diabetes, Vol. 43, No. 5, 05.1994, p. 718-723.

Research output: Contribution to journalArticle

Sturis, J, Kurland, IJ, Byrne, MM, Mosekilde, E, Froguel, P, Pilkis, SJ, Bell, GI & Polonsky, KS 1994, 'Compensation in pancreatic β-cell function in subjects with glucokinase mutations', Diabetes, vol. 43, no. 5, pp. 718-723.
Sturis J, Kurland IJ, Byrne MM, Mosekilde E, Froguel P, Pilkis SJ et al. Compensation in pancreatic β-cell function in subjects with glucokinase mutations. Diabetes. 1994 May;43(5):718-723.
Sturis, Jeppe ; Kurland, Irwin J. ; Byrne, Maria M. ; Mosekilde, Erik ; Froguel, Philippe ; Pilkis, Simon J. ; Bell, Graeme I. ; Polonsky, Kenneth S. / Compensation in pancreatic β-cell function in subjects with glucokinase mutations. In: Diabetes. 1994 ; Vol. 43, No. 5. pp. 718-723.
@article{011379b8a44f4fe093914810ce18e7f5,
title = "Compensation in pancreatic β-cell function in subjects with glucokinase mutations",
abstract = "The relationship between the in vivo insulin secretory responsiveness of the pancreatic β-cell to glucose and the flux of glucose through the enzyme glucokinase was investigated in six subjects with heterozygous glucokinase mutations and in six matched control subjects. This was done by combining data published previously on the in vivo dose-response relationships between glucose and insulin secretion and on the in vitro enzymatic properties of wild-type and mutant forms of glucokinase. The flux of glucose through glucokinase (GK flux) in these subjects was estimated using a model based on the approximate Michaelis-Menten kinetics of wild-type and mutant forms of the enzyme. In two subjects with glucokinase mutations, which resulted in only a small reduction in enzymatic activity, the decrease in insulin secretion was directly proportional to the decrease in GK flux predicted using a Michaelis-Menten model for both mutant and wild-type glucokinase. However, in four subjects with glucokinase mutations, which resulted in severe reductions in enzymatic activity, insulin secretion was reduced compared with control subjects but less than predicted. This latter result implies the existence of a compensatory change in the β-cells of such subjects, which results in a relative increase in insulin secretory response. We propose modifications to the simple model relating glucose concentration and GK flux, including glucose-induced overexpression of the normal allele and a role of glucokinase regulatory protein. The modifications take into account the possibility that the degree of compensation may be directly related to the severity of the mutation.",
author = "Jeppe Sturis and Kurland, {Irwin J.} and Byrne, {Maria M.} and Erik Mosekilde and Philippe Froguel and Pilkis, {Simon J.} and Bell, {Graeme I.} and Polonsky, {Kenneth S.}",
year = "1994",
month = "5",
language = "English (US)",
volume = "43",
pages = "718--723",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "5",

}

TY - JOUR

T1 - Compensation in pancreatic β-cell function in subjects with glucokinase mutations

AU - Sturis, Jeppe

AU - Kurland, Irwin J.

AU - Byrne, Maria M.

AU - Mosekilde, Erik

AU - Froguel, Philippe

AU - Pilkis, Simon J.

AU - Bell, Graeme I.

AU - Polonsky, Kenneth S.

PY - 1994/5

Y1 - 1994/5

N2 - The relationship between the in vivo insulin secretory responsiveness of the pancreatic β-cell to glucose and the flux of glucose through the enzyme glucokinase was investigated in six subjects with heterozygous glucokinase mutations and in six matched control subjects. This was done by combining data published previously on the in vivo dose-response relationships between glucose and insulin secretion and on the in vitro enzymatic properties of wild-type and mutant forms of glucokinase. The flux of glucose through glucokinase (GK flux) in these subjects was estimated using a model based on the approximate Michaelis-Menten kinetics of wild-type and mutant forms of the enzyme. In two subjects with glucokinase mutations, which resulted in only a small reduction in enzymatic activity, the decrease in insulin secretion was directly proportional to the decrease in GK flux predicted using a Michaelis-Menten model for both mutant and wild-type glucokinase. However, in four subjects with glucokinase mutations, which resulted in severe reductions in enzymatic activity, insulin secretion was reduced compared with control subjects but less than predicted. This latter result implies the existence of a compensatory change in the β-cells of such subjects, which results in a relative increase in insulin secretory response. We propose modifications to the simple model relating glucose concentration and GK flux, including glucose-induced overexpression of the normal allele and a role of glucokinase regulatory protein. The modifications take into account the possibility that the degree of compensation may be directly related to the severity of the mutation.

AB - The relationship between the in vivo insulin secretory responsiveness of the pancreatic β-cell to glucose and the flux of glucose through the enzyme glucokinase was investigated in six subjects with heterozygous glucokinase mutations and in six matched control subjects. This was done by combining data published previously on the in vivo dose-response relationships between glucose and insulin secretion and on the in vitro enzymatic properties of wild-type and mutant forms of glucokinase. The flux of glucose through glucokinase (GK flux) in these subjects was estimated using a model based on the approximate Michaelis-Menten kinetics of wild-type and mutant forms of the enzyme. In two subjects with glucokinase mutations, which resulted in only a small reduction in enzymatic activity, the decrease in insulin secretion was directly proportional to the decrease in GK flux predicted using a Michaelis-Menten model for both mutant and wild-type glucokinase. However, in four subjects with glucokinase mutations, which resulted in severe reductions in enzymatic activity, insulin secretion was reduced compared with control subjects but less than predicted. This latter result implies the existence of a compensatory change in the β-cells of such subjects, which results in a relative increase in insulin secretory response. We propose modifications to the simple model relating glucose concentration and GK flux, including glucose-induced overexpression of the normal allele and a role of glucokinase regulatory protein. The modifications take into account the possibility that the degree of compensation may be directly related to the severity of the mutation.

UR - http://www.scopus.com/inward/record.url?scp=0028173718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028173718&partnerID=8YFLogxK

M3 - Article

VL - 43

SP - 718

EP - 723

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 5

ER -